A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Clinical trial NCT07466160 · RECRUITING
Trial details
- NCT number
- NCT07466160
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-11
- Primary completion
- 2027-12-31
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.